1. Home
  2. IRDM vs BEAM Comparison

IRDM vs BEAM Comparison

Compare IRDM & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iridium Communications Inc

IRDM

Iridium Communications Inc

HOLD

Current Price

$16.51

Market Cap

2.0B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$26.06

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRDM
BEAM
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
IRDM
BEAM
Price
$16.51
$26.06
Analyst Decision
Hold
Strong Buy
Analyst Count
5
12
Target Price
$27.60
$48.09
AVG Volume (30 Days)
2.1M
1.9M
Earning Date
10-23-2025
11-04-2025
Dividend Yield
3.62%
N/A
EPS Growth
22.73
N/A
EPS
1.14
N/A
Revenue
$871,710,000.00
$55,701,000.00
Revenue This Year
$7.64
N/A
Revenue Next Year
$1.70
$26.52
P/E Ratio
$14.61
N/A
Revenue Growth
7.30
N/A
52 Week Low
$15.65
$13.53
52 Week High
$34.45
$35.25

Technical Indicators

Market Signals
Indicator
IRDM
BEAM
Relative Strength Index (RSI) 40.11 53.17
Support Level $17.37 $25.53
Resistance Level $19.32 $27.87
Average True Range (ATR) 0.74 1.67
MACD -0.05 -0.03
Stochastic Oscillator 9.75 49.19

Price Performance

Historical Comparison
IRDM
BEAM

About IRDM Iridium Communications Inc

Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: